- Presentations
- 5
- Markets
- 1
Invega Sustenna is a brand of Paliperidone palmitate marketed by Janssen Pharmaceuticals, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Paliperidone palmitate
- Brand owner
- Janssen Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 117 mg/0.75 mL injection, 156 mg/1 mL injection, 234 mg/1.5 mL injection, 39 mg/0.25 mL injection, 78 mg/0.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Invega Sustenna 117 mg/0.75 mL injectionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega Sustenna 156 mg/1 mL injectionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega Sustenna 234 mg/1.5 mL injectionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega Sustenna 39 mg/0.25 mL injectionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega Sustenna 78 mg/0.5 mL injectionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Paliperidone palmitate.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Invega Sustenna
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.